T8	Treatment 98 141	combination therapy with IFN and ribavirin.
T9	Subject 12 37	two dark-skinned patients
T10	Effect 52 90	hyperpigmented skin and tongue lesions
T11	Population 12 15	two
T12	Race 16 28	dark-skinned
T13	Drug 123 126	IFN
T14	Drug 131 140	ribavirin
